SMith J M, Lane V, O'Flynn J D
Urology. 1978 May;11(5):474-7. doi: 10.1016/0090-4295(78)90160-7.
A prospective study to assess the effects of triethylene glycol diglyceridyl ether (Epodyl) in the management of superficial noninvasive vesical neoplasm (T1) is presented. Apart from a few local side effects, the response of the tumor to Epodyl was very good as assessed up to three years. Further long-term studies are being done.
本文介绍了一项前瞻性研究,旨在评估三甘醇二缩水甘油醚(Epodyl)在浅表非侵袭性膀胱肿瘤(T1)治疗中的效果。除了一些局部副作用外,截至三年评估时,肿瘤对Epodyl的反应非常好。进一步的长期研究正在进行中。